Daniel Galbraith

Daniel Galbraith serves as Chief Technology Officer Large Molecules and Advanced Therapies at Solvias. Solvias operates in the pharmaceuticals sector with approximately 620.0 employees. The company is headquartered in Glasgow, Scotland. Solvias generates annual revenue of 2400000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 589 executive contacts are available in Scotland.
• • Our database includes 201,469 c suite-level executives.

Outlook MailChimp SPF Microsoft Office 365 Cloudflare DNS TurboSMTP Leadfeeder Hubspot Google Font API Mobile Friendly AI Remote

analytical services solid state development polymorphism salts & crystallization pharmaceutical development catalysis technology biopharmaceutical analysis api manufacturing biological analysis custom synthesis small molecules analysis ligands extractables leachables quality control troubleshooting cell gene therapy mabs adcs biologics pharmaceutical manufacturing cgmp contract research organization biologics testing cell therapies gene therapies small molecule development method development validation services drug product testing excipient testing raw materials testing release testing stability studies impurity testing contamination control cmc services api development custom solutions genetic qc extractables testing leachables testing risk assessment analytical characterization in vitro studies process analytical technology regulatory compliance pharmaceutical testing clinical trials drug development quality assurance safety testing analytical method validation drug substance characterization small molecule api biopharmaceuticals therapeutic modalities protein analysis characterization studies bioanalysis potency assays molecular characterization quality excellence scientific expertise biopharma innovative therapies project management industry standards customer collaboration cro analytical testing cgmp compliance chemistry manufacturing controls cmc pharmaceutical services biotech support commercialization small molecules cell & gene therapies peptide therapeutics quality management analytical method development pat global reach customer-centric long-term partnerships innovation support life sciences industry pharmaceutical industry biotechnology industry raw material testing final release testing centers of excellence customer feedback industry trust competitive landscape pharmaceuticals medical health care health wellness & fitness hospital & health care productivity

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

How can I contact Daniel Galbraith?

Daniel Galbraith's verified email address is available on MessageCEO. They currently work at Solvias. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Daniel Galbraith lead?

Daniel Galbraith is Chief Technology Officer Large Molecules and Advanced Therapies at Solvias, a company in the pharmaceuticals sector with 620.0 employees. The company is based in Glasgow, Scotland.

What industry is Daniel Galbraith in?

Daniel Galbraith works in the pharmaceuticals industry as Chief Technology Officer Large Molecules and Advanced Therapies at Solvias. MessageCEO provides verified contact information for executives across all major industries.

Is Daniel Galbraith's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Daniel Galbraith's profile is kept up-to-date with the latest available information.

Last updated: April 10, 2026